NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

XOMA Corporation (NASDAQ: XOMA)

 
XOMA Technical Analysis
5
As on 9th Jun 2023 XOMA SHARE Price closed @ 17.21 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 20.75 & Strong Sell for SHORT-TERM with Stoploss of 21.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

XOMASHARE Price

Open 17.28 Change Price %
High 18.13 1 Day -0.53 -2.99
Low 17.00 1 Week 0.21 1.24
Close 17.21 1 Month -1.62 -8.60
Volume 33758 1 Year -5.35 -23.71
52 Week High 29.61 | 52 Week Low 15.90
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
XOMA
Daily Charts
XOMA
Intraday Charts
Whats New @
Bazaartrend
XOMA
Free Analysis
 
XOMA Important Levels Intraday
RESISTANCE19.39
RESISTANCE18.69
RESISTANCE18.26
RESISTANCE17.83
SUPPORT16.59
SUPPORT16.16
SUPPORT15.73
SUPPORT15.03
 
XOMA Forecast April 2024
4th UP Forecast32.26
3rd UP Forecast27.43
2nd UP Forecast24.45
1st UP Forecast21.47
1st DOWN Forecast12.95
2nd DOWN Forecast9.97
3rd DOWN Forecast6.99
4th DOWN Forecast2.16
 
XOMA Weekly Forecast
4th UP Forecast22.49
3rd UP Forecast20.80
2nd UP Forecast19.75
1st UP Forecast18.70
1st DOWN Forecast15.72
2nd DOWN Forecast14.67
3rd DOWN Forecast13.62
4th DOWN Forecast11.93
 
XOMA Forecast2024
4th UP Forecast48.83
3rd UP Forecast38.69
2nd UP Forecast32.42
1st UP Forecast26.15
1st DOWN Forecast8.27
2nd DOWN Forecast2
3rd DOWN Forecast-4.27
4th DOWN Forecast-14.41
 
 
XOMA Other Details
Segment EQ
Market Capital 286512704.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
XOMA Address
XOMA
 
XOMA Latest News
 
Your Comments and Response on XOMA Corporation
 
XOMA Business Profile
XOMA Corporation, a biotechnology royalty aggregator, engages in helping biotech companies for improving human health. The company acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. It acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance internal drug candidate or for general corporate purposes. The company has a portfolio with approximately 70 assets. It has a pipeline of monoclonal antibodies and technologies available to license to pharmaceutical and biotechnology companies to further clinical development include PTH1R program, an anti-parathyroid receptor pipeline to address unmet medical needs, including primary hyperparathyroidism and humoral hypercalcemia of malignancy; XMetA, an insulin receptor-activating antibody to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; and X213, an allosteric inhibitor of prolactin action. The company also licenses antibody discovery, optimization, and development technologies. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Address: 2200 Powell Street, Emeryville, CA, United States, 94608
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service